# Fish Oil Sleep Randomized Trial: What the Evidence Says
Canonical: https://www.migaku.app/guides/fish-oil-sleep-randomized-trial-evidence-review
Category: evidence-review
Summary: Fish Oil Sleep Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomi
Last reviewed: 2026-06-23
Reviewed by: Migaku Evidence Review
# Fish Oil Sleep Randomized Trial: What the Evidence Says

## Quick Answer

Fish Oil Sleep Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 2 randomized trial.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Effects of omega-3 PUFA-enriched egg consumption on metabolic parameters in elderly adults with metabolic syndrome: study protocol for a randomized controlled trial | randomized trial | 2 | 2026-06-04 | PMC13226538 |
| Twelve-week combined arginine and fish oil supplementation is associated with reduced sarcopenia severity: a randomized, double-blind, placebo-controlled study | randomized trial | 2 | 2026-03-02 | 10.3389/fnut.2026.1763219 |

## What The Sources Report

- Effects of omega-3 PUFA-enriched egg consumption on metabolic parameters in elderly adults with metabolic syndrome: study protocol for a randomized controlled trial [Yang H (2026); evidence level 2]
- This condition is strongly associated with functional decline and increased disability risk, substantially impacting healthcare systems worldwide. [Yuan Weixia (2026); evidence level 2]
- Key contributing factors include the downregulation of anabolic hormones (insulin, sex steroids, and growth hormone), increased muscle fiber apoptosis, and elevated circulating levels of pro-inflammatory cytokines (-). [Yuan Weixia (2026); evidence level 2]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For fish oil sleep randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Yang H (2026). Effects of omega-3 PUFA-enriched egg consumption on metabolic parameters in elderly adults with metabolic syndrome: study protocol for a randomized controlled trial. PMCID: PMC13226538. https://pmc.ncbi.nlm.nih.gov/articles/PMC13226538/
- Yuan Weixia (2026). Twelve-week combined arginine and fish oil supplementation is associated with reduced sarcopenia severity: a randomized, double-blind, placebo-controlled study. DOI: 10.3389/fnut.2026.1763219. PMCID: PMC12989373. PMID: 41847233. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12989373/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.